Novel approach identifies highly specific anti-cancer compounds
Researchers have identified potent, highly specific compounds that interfere with bromodomain (BD)-containing proteins involved in cancer. The compounds, called BET BD1-inhibitors, are a starting point in the development of potentially more effective anti-cancer drugs with less side effects.
Materials provided by Baylor College of Medicine. Note: Content may be edited for style and length.
Source link aaaaa